89ZR-TRASTUZUMAB-PET, RAPID AUTOPSIES, AND PATIENT-DERIVED XENOGRAFTS TO DETERMINE THE EXTENT OF CLONAL EVOLUTION IN TREATMENT-REFRACTORY HER2+ GASTR
$666,525FY2016Department of DefenseDOD
Sloan-Kettering Institute For Cancer Research
Sloan-Kettering Institute For Cancer Research